期刊文献+

人乳头瘤病毒感染与P53及肺耐药蛋白表达在非小细胞肺癌中的关系及其临床意义 被引量:1

The relationship among human papillomavirus infection and the expression of protein P53 and LRP in non-small-cell lung cancer
下载PDF
导出
摘要 目的:探讨人乳头瘤病毒(humanpapillomavirus,HPV)感染在非小细胞肺癌(non-small-celllungcancer,NSCLC)发生中的病因学意义及其与P53蛋白和肺耐药蛋白(lungresistanceprotein,LRP)表达之间的相关性。方法:应用聚合酶链反应(PCR)、免疫组化方法(IHC)分别检测76例NSCLC组织中HPVDNA及其E6、E7原癌蛋白,P53和LRP蛋白的表达情况。结果:NSCLC中HPVDNA及其E6、E7原癌蛋白的检出率分别为40.8%、43.4%,2种方法检测的符合率为78.9%;P53和LRP的阳性率分别为63.2%、59.2%,且HPV感染阳性组中P53蛋白阳性表达率(75.8%)显著高于阴性组(46.5%)(P<0.05);P53蛋白表达阳性组中LRP阳性表达率(68.8%)显著高于阴性组(42.9%)(P<0.05);而HPV感染阳性组与阴性组间LRP的表达无显著性差异(P>0.05)。HPV感染与高、中分化程度的NSCLC及吸烟有关;结论:HPV感染可能是NSCLC发生的另一重要病因学因素,且HPV感染可能导致P53基因突变,同时基因突变的P53可能促进肺癌耐药性的增加。 Objective: To investigate the relationship among human papiUomavirus(HPV) infection and the expression of protein P53 and lung resistance protein (LRP) in non-small-cell lung cancer (NSCLC). Methods: PCR and S-P immunohistochemical (IHC)method were used respectively to examine the expressions of HPV DNA,HPV E6,E7 protein, P53 and LRP in the 76 cases with NSCLC. Results: Of 76 cases with NSCLC,the positive percentage of HPV DNA,HPV E6,E7 protein,P53 and LRP were 40.8%,43.4%,63.2%,59.2% respectively. The coincident rates of both PCR and IHC methods were 78.9%. The percentage of positive of P53 protein was evidently higher in the group of HPV infection(75.8%)than in the negative group(46.5%)(P〈0.05); the percentage of positive of LRP was significantly higher in the group of P53 positive (68.8%)than in the negative group (42.9%)(P〈0.05). But LRP expressions were not significantly difference between positive and negative HPV infection groups(P〉0.05). The expression of HPV was significantly correlated with the high and middle degree of carcinoma differentiation of NSCLC and smoking. Conclusions: HPV infection may be another important etiological factors that result in the occurrence of NSCLC. HPV infection may induce the mutation of P53 gene and the mutative P53 may increase the drug resistance of the lung cancer.
出处 《海南医学院学报》 CAS 2005年第6期494-497,共4页 Journal of Hainan Medical University
基金 海南省自然科学基金(30321)
关键词 乳头状瘤病毒 非小细胞肺 基因 P53 蛋白质P53 聚合酶链反应 免疫组织化学 HPV Cancer, Non-small-cell Gene, P53 protein P53 Polymerase chain reaction (PC R) Immunohistochemistry
  • 相关文献

参考文献9

  • 1McMurray HR,Nguyen D,Westbrook TF,et al.Biology of human papillomaviruses[J].Iht J Exp Pathol,2001,82(1):15-33.
  • 2姜蕊,吴翠环,郑丽端,赵时宇,陈多恩.人乳头瘤病毒感染与非小细胞肺癌发生的相关性[J].华中科技大学学报(医学版),2005,34(2):141-144. 被引量:9
  • 3Bodey B,Bodey B,Croger AM,et al.Immunocytochemical detection of the P170 multidrug resistance (MDR) and the p53 tumor suppressor gene proteins in human breast cancer cell:clinical and therapeutical significance[J].Anticancer Res,1997,17(2):1311-1318.
  • 4郑少江,吴人亮,郭峻莉,郑少萍,王志华,焦嫦亮,汪永平.非小细胞肺癌中肺耐药蛋白、酸性谷胱甘肽-S-转移酶的协同表达及其临床意义[J].华中科技大学学报(医学版),2005,34(1):13-16. 被引量:7
  • 5Syrjanen KJ.Bronchial squamous cell carcinomas associated with epithelial changes identical to condylomatous lesions of the uterine cervix[J].Lung,1979,158:131.
  • 6Burger MPM,Hollema H,Gouw ASH,et al.Cigarette smoking and human papillomavirus in patients with reported cervical cytological abnormality[J].Br Med J,1993,306 (4):749-752.
  • 7Kessis TD,Slebos R J,NelsonWG,et al.Human papilloma-virus16 E6expression disrupts the p53-mediated cellular response to DNA damage[J].Proc Natl Acad Sci USA,1993,90(9):3988.
  • 8Izquierdo MA,Scheffer GL,Flens MJ,et al.Majorvault protein LRP related muitidrug resistance.Eur J Cancer,1996,32:979-984.
  • 9Chin KV,Ueda K,Pastan I,et al.Modulation of activity of the promoter of the human MDR gene by Ras and P53[J].Science,1992,255(3):495-462.

二级参考文献17

  • 1Herbst R S,Dang N H,Skarin A T. Chemotherapy for advanced non-small cell lung cancer.Hematol Oncol Clin North Am, 1997,11:473.
  • 2Goto S,IidaT,Chos G.Over expression of glutathione-S-transferase π enhances the adduct formation of cisplatin with glutathione in human cancer cells.Free Radi Res,1999,31:549.
  • 3Cheffer G L,Wijngaard P L,Flens M J et al.The drug resistance related protein LRP is the human major vault protein.Nat Med,1995,6:578.
  • 4Izquierdo M A,van der Zee A G,Vermorken J B et al.Durg resistance-associated marker LRP for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma. J Natl Cancer Inst,1995,87:1230.
  • 5Scheper R J,Broxterman H J,Scheffer G L et al.Overexpression of a M(r)110.000 vesicular protein in non-P-glycoprotein-mediated muitidrug resistance.Cancer Res,1993,53:1475.
  • 6Izquierdo M A,Scheffer G L,Flens M J et al.Majorvault protein LRP related muitidrug resistance. Eur J Cancer,1996,32A:979.
  • 7Silvestrini R,Veneroni S,Benini E et al.Expression of p53,glutathione S-transferase-π,and Bcl-2 proteins and benefit from adjuvant radiotherapy in breast cancer.J Natl Cancer Inst,1997,89:639.
  • 8Manos M M,Ting Y, Wight D K. Use of polymerase chain reaction amplification for the detection of genital human papillomavirus. Cancer Cells,1989,7:209
  • 9Kionshita M, Shin S, Aono T. A sensitive and quantitative method for the determination of number of HPV16 DNA copies by using the compeitine PCR. Proc Natr Soc,1994,53:605
  • 10Evander M,Boden E, Bjersing L et al. Oligonucleotide primers for DNA amplification of early region 1,6 and 7 form human papillomavirus type 6,11,16,18,31 and 33. Arch Virol, 1991,116 :221

共引文献13

同被引文献1

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部